We were inspired by a recent PharmaLive story on Lilly’s new initiative highlighting the key work that medical professionals undertake at the company during all facets and phases of drug discovery and development.
The story notes that over 500 physicians, 700 pharmacists, and 1400 medical research scientists work at Lilly, and the company is touting their work with the medical community to bring new treatments to market, all while keeping patient needs first.
While many are either skeptical or unaware of these interactions, the article speaks to why we are in the business of what we do at Thought Leader Select—delivering key information to pharmaceutical, biotechnology, and medical device companies so that external relations officials at companies like Lilly can optimize their medical community interactions in the service of patients.
Companies in life science disciplines utilize key opinion leaders in medicine in a host of ways to ensure that new treatments target unmet medical needs and have the best impact possible on patient outcomes. Their collaborative work results in clinical research, patient advocacy, bioethics, regulatory compliance, and medical education, all key drivers in medicine today.
Thought Leader Select is proud that our work in identifying and profiling the right key opinion leaders and medical centers of excellence to collaborate with industry in these many contexts and more optimizes these industry/medical community relationships for more than 40 leading companies. Our work plays a foundational role in areas with far-reaching impacts like diabetes, COPD, and a number of oncology specialties, as well as an array of rare conditions affecting neurological, gastrointestinal, and cardiovascular organs and systems.
It’s critical for the public to understand that these interactions among industry-based medical professionals and their counterparts in clinical and research settings are pivotal to the future of healthcare both in the US and around the world. Industry regulations and ethics demand that these interactions continue with the utmost sense of both purpose and transparency. The business of healthcare is highly profitable in nature, but it isn’t without tremendous risks, both reputational and real for companies, their collaborators in medicine, and most of all, for the patients who rely on industry and health care professionals to deliver better treatments for better outcomes year after year.
Check out Lilly’s video, Patients Matter Most, on YouTube—the video is part of an awareness campaign aimed at showing the company’s commitment to patients through working with healthcare professionals, both internally and externally.
